Daniel Keebler, PhD, SM (he/him/his)

Director, Pharmacoepidemiology
Regeneron Pharmaceuticals

Poster(s):

• (051) Background rates of cardiovascular events in patients at high risk of severe COVID-19 before and during the COVID-19 pandemic
  Friday, August 25, 2023

  8:00 AM – 6:00 PM ADT

• (139) Background Rates of Pediatric-Onset Type I Diabetes Before and During the COVID-19 Pandemic
  Friday, August 25, 2023

  8:00 AM – 6:00 PM ADT

• (B50) Comparing approaches to achieving exact balance on key covariates in propensity score matched analyses: a simulation study
  Saturday, August 26, 2023

  8:00 AM – 6:00 PM ADT